Genor Biopharma Holdings Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Genor Biopharma Holdings.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 35.0% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
We Think Genor Biopharma Holdings (HKG:6998) Needs To Drive Business Growth Carefully
Dec 29
We're Hopeful That Genor Biopharma Holdings (HKG:6998) Will Use Its Cash Wisely
Dec 21Is Genor Biopharma Holdings (HKG:6998) In A Good Position To Deliver On Growth Plans?
Sep 05We Think Genor Biopharma Holdings (HKG:6998) Can Afford To Drive Business Growth
Dec 03Here's Why We're Not Too Worried About JHBP (CY) Holdings' (HKG:6998) Cash Burn Situation
Aug 28Is JHBP (CY) Holdings (HKG:6998) In A Good Position To Invest In Growth?
May 10In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Genor Biopharma Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | N/A | -674 | N/A | N/A | N/A |
| 9/30/2023 | 6 | -637 | N/A | N/A | N/A |
| 6/30/2023 | 13 | -599 | -500 | -496 | N/A |
| 3/31/2023 | 14 | -665 | -545 | -537 | N/A |
| 12/31/2022 | 16 | -730 | -591 | -578 | N/A |
| 9/30/2022 | 9 | -800 | -627 | -604 | N/A |
| 6/30/2022 | 3 | -870 | -663 | -630 | N/A |
| 3/31/2022 | 1 | -868 | -679 | -627 | N/A |
| 12/31/2021 | N/A | -865 | -695 | -624 | N/A |
| 9/30/2021 | 3 | -1,880 | -749 | -646 | N/A |
| 6/30/2021 | 7 | -2,895 | -803 | -668 | N/A |
| 3/31/2021 | 10 | -3,086 | -959 | -845 | N/A |
| 12/31/2020 | 10 | -3,027 | -885 | -787 | N/A |
| 3/31/2020 | 12 | -590 | -160 | -131 | N/A |
| 12/31/2019 | 13 | -522 | -138 | -111 | N/A |
| 12/31/2018 | 7 | -288 | -283 | -253 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 6998's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if 6998's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 6998's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 6998's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 6998's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 6998's Return on Equity is forecast to be high in 3 years time